1. Home
  2. APPN vs XNCR Comparison

APPN vs XNCR Comparison

Compare APPN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Appian Corporation

APPN

Appian Corporation

N/A

Current Price

$38.14

Market Cap

2.5B

Sector

Technology

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$24.58

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APPN
XNCR
Founded
1999
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
APPN
XNCR
Price
$38.14
$24.58
Analyst Decision
Hold
Buy
Analyst Count
7
14
Target Price
★ $34.00
$31.42
AVG Volume (30 Days)
726.6K
★ 1.0M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 101.59
65.36
EPS
★ N/A
N/A
Revenue
★ $226,743,000.00
$125,576,000.00
Revenue This Year
$16.88
$14.05
Revenue Next Year
$10.78
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 28.29
13.65
52 Week Low
$18.63
$10.38
52 Week High
$46.06
$30.61

Technical Indicators

Market Signals
Indicator
APPN
XNCR
Relative Strength Index (RSI) 51.04 51.52
Support Level $33.28 $23.36
Resistance Level $39.67 $30.61
Average True Range (ATR) 1.78 1.03
MACD -0.40 -0.09
Stochastic Oscillator 53.40 55.23

Price Performance

Historical Comparison
APPN
XNCR

About APPN Appian Corporation

Appian Corp is an enterprise software company whose platform unifies process orchestration, artificial intelligence, and data for automating complex business operations. Its platform combines low-code application development, process automation and process mining, AI agents, and a data fabric that connects information across an organization's existing systems without replicating it. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based, with the remainder coming from services, and much of that subscription revenue comes from its cloud-based platform. Geographically, the company derives maximum revenue from its Domestic operations and also has a presence internationally.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: